Logo image of NS

NUSTAR ENERGY LP (NS) Stock Fundamental Analysis

NYSE:NS - New York Stock Exchange, Inc. - US67058H1023 - Currency: USD

21.96  -0.41 (-1.83%)

After market: 22 +0.04 (+0.18%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NS. NS was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. There are concerns on the financial health of NS while its profitability can be described as average. NS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year NS was profitable.
In the past year NS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NS reported negative net income in multiple years.
Each year in the past 5 years NS had a positive operating cash flow.
NS Yearly Net Income VS EBIT VS OCF VS FCFNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

1.2 Ratios

With a Return On Assets value of 0.71%, NS is not doing good in the industry: 77.67% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 3.38%, NS is doing worse than 74.42% of the companies in the same industry.
The Return On Invested Capital of NS (7.74%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for NS is significantly below the industry average of 23.98%.
The last Return On Invested Capital (7.74%) for NS is above the 3 year average (7.42%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.71%
ROE 3.38%
ROIC 7.74%
ROA(3y)0.14%
ROA(5y)-1.9%
ROE(3y)1.41%
ROE(5y)-5.01%
ROIC(3y)7.42%
ROIC(5y)6.81%
NS Yearly ROA, ROE, ROICNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

NS has a Profit Margin of 2.11%. This is in the lower half of the industry: NS underperforms 73.02% of its industry peers.
NS's Operating Margin of 27.84% is in line compared to the rest of the industry. NS outperforms 56.28% of its industry peers.
NS's Operating Margin has improved in the last couple of years.
NS's Gross Margin of 36.89% is in line compared to the rest of the industry. NS outperforms 43.72% of its industry peers.
NS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.84%
PM (TTM) 2.11%
GM 36.89%
OM growth 3Y-0.68%
OM growth 5Y5.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y4.79%
NS Yearly Profit, Operating, Gross MarginsNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NS is still creating some value.
The number of shares outstanding for NS has been increased compared to 1 year ago.
NS has more shares outstanding than it did 5 years ago.
NS has a worse debt/assets ratio than last year.
NS Yearly Shares OutstandingNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
NS Yearly Total Debt VS Total AssetsNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

NS has a debt to FCF ratio of 10.32. This is a negative value and a sign of low solvency as NS would need 10.32 years to pay back of all of its debts.
NS has a Debt to FCF ratio (10.32) which is in line with its industry peers.
NS has a Debt/Equity ratio of 3.33. This is a high value indicating a heavy dependency on external financing.
NS has a worse Debt to Equity ratio (3.33) than 87.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.33
Debt/FCF 10.32
Altman-Z N/A
ROIC/WACC1.06
WACC7.28%
NS Yearly LT Debt VS Equity VS FCFNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.81 indicates that NS may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.81, NS is doing worse than 72.09% of the companies in the same industry.
NS has a Quick Ratio of 0.81. This is a bad value and indicates that NS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of NS (0.73) is worse than 67.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.73
NS Yearly Current Assets VS Current LiabilitesNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

NS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.22%.
The Earnings Per Share has been decreasing by -4.28% on average over the past years.
The Revenue has decreased by -2.17% in the past year.
The Revenue has been growing slightly by 1.46% on average over the past years.
EPS 1Y (TTM)-1.22%
EPS 3YN/A
EPS 5Y-4.28%
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-2.17%
Revenue growth 3Y3.32%
Revenue growth 5Y1.46%
Sales Q2Q%-0.78%

3.2 Future

Based on estimates for the next years, NS will show a very strong growth in Earnings Per Share. The EPS will grow by 21.67% on average per year.
The Revenue is expected to grow by 0.91% on average over the next years.
EPS Next Y53.78%
EPS Next 2Y34.12%
EPS Next 3Y21.67%
EPS Next 5YN/A
Revenue Next Year6.8%
Revenue Next 2Y3.96%
Revenue Next 3Y0.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NS Yearly Revenue VS EstimatesNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
NS Yearly EPS VS EstimatesNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

NS is valuated quite expensively with a Price/Earnings ratio of 27.11.
NS's Price/Earnings ratio is a bit more expensive when compared to the industry. NS is more expensive than 75.81% of the companies in the same industry.
When comparing the Price/Earnings ratio of NS to the average of the S&P500 Index (26.29), we can say NS is valued inline with the index average.
A Price/Forward Earnings ratio of 13.56 indicates a correct valuation of NS.
The rest of the industry has a similar Price/Forward Earnings ratio as NS.
NS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.11
Fwd PE 13.56
NS Price Earnings VS Forward Price EarningsNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

NS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NS is more expensive than 60.93% of the companies in the same industry.
NS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NS is cheaper than 69.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.44
EV/EBITDA 8.68
NS Per share dataNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NS's earnings are expected to grow with 21.67% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y34.12%
EPS Next 3Y21.67%

More info and screens

5

5. Dividend

5.1 Amount

NS has a Yearly Dividend Yield of 7.29%, which is a nice return.
NS's Dividend Yield is a higher than the industry average which is at 6.81.
Compared to an average S&P500 Dividend Yield of 2.38, NS pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.29%

5.2 History

The dividend of NS decreases each year by -8.34%.
NS has been paying a dividend for at least 10 years, so it has a reliable track record.
NS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-8.34%
Div Incr Years0
Div Non Decr Years2
NS Yearly Dividends per shareNS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4

5.3 Sustainability

861.28% of the earnings are spent on dividend by NS. This is not a sustainable payout ratio.
DP861.28%
EPS Next 2Y34.12%
EPS Next 3Y21.67%
NS Yearly Income VS Free CF VS DividendNS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M
NS Dividend Payout.NS Dividend Payout, showing the Payout Ratio.NS Dividend Payout.PayoutRetained Earnings

More info and screens

NUSTAR ENERGY LP

NYSE:NS (5/2/2024, 8:10:13 PM)

After market: 22 +0.04 (+0.18%)

21.96

-0.41 (-1.83%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-02 2024-05-02/bmo
Earnings (Next)08-01 2024-08-01/bmo
Inst Owners0.18%
Inst Owner Change-93.52%
Ins Owners8.18%
Ins Owner Change0%
Market Cap2.78B
Analysts46.67
Price Target23.46 (6.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.29%
Yearly Dividend2.53
Dividend Growth(5Y)-8.34%
DP861.28%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.88%
Min EPS beat(2)-51.46%
Max EPS beat(2)31.7%
EPS beat(4)1
Avg EPS beat(4)-29.85%
Min EPS beat(4)-66.85%
Max EPS beat(4)31.7%
EPS beat(8)1
Avg EPS beat(8)-34.12%
EPS beat(12)2
Avg EPS beat(12)-78.1%
EPS beat(16)2
Avg EPS beat(16)-118.28%
Revenue beat(2)1
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-7.85%
Max Revenue beat(2)1.12%
Revenue beat(4)2
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-7.85%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)-4.7%
Revenue beat(12)7
Avg Revenue beat(12)-1.56%
Revenue beat(16)8
Avg Revenue beat(16)-1.82%
PT rev (1m)0.73%
PT rev (3m)21.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.58%
EPS NY rev (1m)0%
EPS NY rev (3m)4.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.72%
Valuation
Industry RankSector Rank
PE 27.11
Fwd PE 13.56
P/S 1.7
P/FCF 8.44
P/OCF 5.68
P/B 2.73
P/tB N/A
EV/EBITDA 8.68
EPS(TTM)0.81
EY3.69%
EPS(NY)1.62
Fwd EY7.37%
FCF(TTM)2.6
FCFY11.85%
OCF(TTM)3.87
OCFY17.61%
SpS12.89
BVpS8.05
TBVpS-1.42
PEG (NY)0.5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 3.38%
ROCE 9.8%
ROIC 7.74%
ROICexc 7.75%
ROICexgc 10.46%
OM 27.84%
PM (TTM) 2.11%
GM 36.89%
FCFM 20.19%
ROA(3y)0.14%
ROA(5y)-1.9%
ROE(3y)1.41%
ROE(5y)-5.01%
ROIC(3y)7.42%
ROIC(5y)6.81%
ROICexc(3y)7.43%
ROICexc(5y)6.85%
ROICexgc(3y)10.05%
ROICexgc(5y)9.37%
ROCE(3y)9.39%
ROCE(5y)8.62%
ROICexcg growth 3Y8.07%
ROICexcg growth 5Y11.61%
ROICexc growth 3Y7.97%
ROICexc growth 5Y12.53%
OM growth 3Y-0.68%
OM growth 5Y5.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.12%
GM growth 5Y4.79%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 3.33
Debt/FCF 10.32
Debt/EBITDA 4.77
Cap/Depr 62.33%
Cap/Sales 9.81%
Interest Coverage 1.93
Cash Conversion 68.84%
Profit Quality 955.94%
Current Ratio 0.81
Quick Ratio 0.73
Altman-Z N/A
F-Score4
WACC7.28%
ROIC/WACC1.06
Cap/Depr(3y)59.31%
Cap/Depr(5y)87.39%
Cap/Sales(3y)9.52%
Cap/Sales(5y)15.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.22%
EPS 3YN/A
EPS 5Y-4.28%
EPS Q2Q%-37.5%
EPS Next Y53.78%
EPS Next 2Y34.12%
EPS Next 3Y21.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.17%
Revenue growth 3Y3.32%
Revenue growth 5Y1.46%
Sales Q2Q%-0.78%
Revenue Next Year6.8%
Revenue Next 2Y3.96%
Revenue Next 3Y0.91%
Revenue Next 5YN/A
EBIT growth 1Y-3.23%
EBIT growth 3Y2.62%
EBIT growth 5Y6.92%
EBIT Next Year30.44%
EBIT Next 3Y10.81%
EBIT Next 5Y7.72%
FCF growth 1Y0.35%
FCF growth 3Y3.8%
FCF growth 5Y33.44%
OCF growth 1Y-2.43%
OCF growth 3Y-0.75%
OCF growth 5Y-1.13%